Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation

被引：0
|
作者：
Miekarek, Marco [1 ,2 ]
Furlong, Terry [1 ]
O'Donnell, Paul V. [1 ]
Storer, Barry E. [1 ]
McCune, Jeannine S. [1 ]
Storb, Rainer F. [2 ,3 ]
Carpenter, Paul A. [1 ]
Flowers, Mary E. D. [1 ,2 ]
Appelbaum, Frederick R. [1 ,2 ]
Martin, Paul J. [1 ,2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[2] Univ Washington, Dept Med, Seattle, WA USA
[3] Fred Hutchinson Canc Res Ctr, Div Clin Res, Transplantat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2016年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [21] Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Ghanem, Sassine
    Alousi, Amin M.
    Rondon, Gabriela
    Anderlini, Paolo
    Al-Atrash, Gheath
    Bashir, Qaiser
    Hosing, Chitra M.
    Im, Jin S.
    Kebriaei, Partow
    Khouri, Issa
    Marin, David
    Nieto, Yago
    Olson, Amanda
    Oran, Betul
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Ramdial, Jeremy
    Saini, Neeraj
    Srour, Samer A.
    Champlin, Richard E.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (07): : 395.e1 - 395.e11
  • [22] Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study
    Juarez, Alex
    Salas, Maria Queralt
    Pedraza, Alexandra
    Suarez-Lledo, Maria
    Rodriguez-Lobato, Luis Gerardo
    Solano, Maria Teresa
    Serrahima, Anna
    Nomdedeu, Meritxell
    Cid, Joan
    Lozano, Miquel
    Charry, Paola
    Arcarons, Jordi
    Llobet, Noemi
    Rosinol, Laura
    Fernandez-Aviles, Francesc
    Rovira, Montserrat
    Martinez, Carmen
    CANCERS, 2024, 16 (14)
  • [23] Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
    Nunes, Natalia S.
    Kanakry, Christopher G.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [24] The Use of Post-transplantation Cyclophosphamide in Peripheral Blood HLA-matched Stem Cell Transplantation as Graft-versus-host Disease Prophylaxis in Patients With Malignant or Non-malignant Hematologic Disorders: A Single-center Experience of 52 Patients
    Mahmoud, Hossam Kamel
    Fathy, Gamal Mohamed
    Elhaddad, Alaa
    Fahmy, Omar A.
    Abdel-Mooti, Mohamed
    Abdelfattah, Raafat
    Bokhary, Mahmoud
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10): : 677 - 684
  • [25] Impact of donor and recipient characteristics on graft-versus-host disease and survival in HLA-matched sibling hematopoietic stem cell transplantation
    Zhang, Haiyan
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (03)
  • [26] Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
    Cutler, C
    Kim, HT
    Hochberg, E
    Ho, V
    Alyea, E
    Lee, SJ
    Fisher, DC
    Miklos, D
    Levin, J
    Sonis, S
    Soiffer, RJ
    Antin, JH
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (05) : 328 - 336
  • [27] A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation
    Lee, Myung-Won
    Yeon, Sang Hoon
    Seo, Won-Hyoung
    Ryu, Hyewon
    Lee, Hyo-Jin
    Yun, Hwan-Jung
    Jo, Deog-Yeon
    Song, Ik-Chan
    MEDICINE, 2020, 99 (34) : E21571
  • [28] Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
    Kanakry, Jennifer A.
    Kasamon, Yvette L.
    Bolanos-Meade, Javier
    Borrello, Ivan M.
    Brodsky, Robert A.
    Fuchs, Ephraim J.
    Ghosh, Nilanjan
    Gladstone, Douglas E.
    Gocke, Christopher D.
    Huff, Carol Ann
    Kanakry, Christopher G.
    Luznik, Leo
    Matsui, William
    Mogri, Huzefa J.
    Swinnen, Lode J.
    Symons, Heather J.
    Jones, Richard J.
    Anibinder, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (10) : 1514 - 1517
  • [29] Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
    Williams, Louis
    Cirrone, Frank
    Cole, Kelli
    Abdul-Hay, Maher
    Luznik, Leo
    Al-Homsi, Ahmad Samer
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [30] Efficacy of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Peripheral Blood Stem Cell HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation; A Prospective Pilot Trial
    Al Malki, Monzr M.
    Tsai, Ni-Chun
    Palmer, Joycelynne
    Mokhtari, Saloomeh
    Cao, Thai
    Ali, Haris
    Salhotra, Amandeep
    Arslan, Shukaib
    Aldoss, Ibrahim
    Karras, Nicole
    Ali, Haris M.
    Ali, Haris
    Stein, Anthony S.
    Snyder, David S.
    Marcucci, Guido
    Forman, Stephen J.
    Nakamura, Ryotaro
    BLOOD, 2020, 136
12345